Emerging Markets Regulatory Tracker: China GSPs, Indian BE Testing
This article was originally published in PharmAsia News
Executive Summary
China has issued new Good Supply Practice regulations for medical devices, while India is changing the format of requests for bioequivalence studies for drugs to be exported.